New shingles vaccine linked to lower risk of coronary heart disease, stroke and heart failure – major study indicates
26 August 2026
The shingles vaccine currently in use, called ‘Shingrix’, is associated with a reduced risk of cardiovascular events – including heart attacks, heart failure and stroke – compared to the previous shingles vaccine, according to a major new study published in Nature Medicine.
Vapes help more people quit smoking than other methods, Oxford-led Cochrane review finds
26 August 2026
An updated Cochrane review led by Oxford researchers finds nicotine e-cigarettes help more people quit smoking than nicotine patches and gum, behavioural support or no support. The living review now includes 80 trials and nearly 30,000 participants.
Brain imaging study reveals how we decide whether we are in control
25 August 2026
A brain imaging and stimulation study led by the University of Oxford has identified the brain mechanisms that help us work out whether the consequences we experience are caused by our own actions or by circumstances beyond our control.
Semaglutide associated with fewer cognitive problems in people with mental illness
24 August 2026
Semaglutide, widely used to treat diabetes and obesity, was associated with fewer cognitive signs and symptoms in people with psychiatric disorders, according to a new study led by researchers at the University of Oxford.
Oxford researchers win prestigious national leadership prizes
20 August 2026
Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo, both from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contributions to health and care research.
A new layer of control for a decades-old leukemia drug
19 August 2026
How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from the Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.
Study of 3,400 children links London's Ultra Low Emission Zone with improved lung growth
19 August 2026
The proportion of London children with clinically impaired lung function fell from around one in seven to one in 11 over five years following the introduction of London’s Ultra Low Emission Zone (ULEZ), according to a major five-year study jointly led by researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford.
New open-source tool helps researchers test robustness of findings
14 August 2026
Oxford researchers launch RobustiPy, a new open-source tool designed to ensure research is robust and reliable.
Arthritis origins may begin before birth, study finds
12 August 2026
Researchers at the Kennedy Institute (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.
100th patient enrolled in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease
12 August 2026
This milestone, reached just 12 weeks after the announcement of the outbreak, makes PARTNERS the fastest-ever randomised controlled trial of treatments for Ebola.
Statins reduce hospital admissions but increase overall healthcare use
11 August 2026
Study finds statins reduce healthcare use initially, but longer lives mean greater overall demand for health services over time
New audit system maps how mental health risks emerge in AI chatbot conversations
7 August 2026
Scientists have developed a framework for stress-testing how AI chatbots respond to vulnerable users, helping researchers identify weaknesses and test ways of making mental-health interactions safer.
Expert Comment: Climate-friendly food procurement and advertising: what are local authorities in England doing?
6 August 2026
Professor Mike Rayner (Nuffield Department of Population Health), Dr Jessica Renzella (Nuffield Department of Primary Care Health Sciences) and Dr Hannah Forde (Nuffield Department of Primary Care Health Sciences) argue that local authorities could play a significant role in steering UK diets to become healthier and more sustainable.
Oxford researchers uncover how Parkinson's disease protein damages brain cells
5 August 2026
A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.
Combination of tobacco control policies needed to further reduce smoking deaths
4 August 2026
Studies have shown that long‑term quitters who haven’t smoked for 10 years or more get back almost all of the lost life. Saving more lives needs combined measures.
The Global Health Network joins the Nuffield Department of Primary Care Health Sciences
4 August 2026
The Global Health Network, a WHO Collaborating Centre with more than one million members worldwide, has joined the Nuffield Department of Primary Care Health Sciences, strengthening the department's work to advance global primary health care.
New study highlights importance of heart disease treatments targeting both cholesterol and inflammation
29 July 2026
The study identifies 12 proteins that could lead to new heart disease treatments targeting both cholesterol and inflammation.
Tommy’s National Centre for Miscarriage Research celebrates ten years of progress
28 July 2026
Tommy's National Centre for Miscarriage Research marks ten years of pioneering research, with the Nuffield Department of Women's & Reproductive Health now leading the next phase of its work to improve miscarriage care and prevention.
Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient
28 July 2026
The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.
First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial
24 July 2026
The University of Oxford’s Oxford Vaccine Group has today successfully vaccinated the first volunteer in the world’s first clinical trial of a vaccine designed to protect against Bundibugyo ebolavirus (BDBV).
